Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01713569
What this trial is testing

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

Who this might be right for
Skin Laxity
Ulthera, Inc 2
Not applicableLooking for participantsNCT07404644
What this trial is testing

An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

Who this might be right for
Von Willebrand Disease (vWD)
Takeda 13
Very early researchUnknownNCT05152732
What this trial is testing

Safety and Tolerability of VGB-R04 in Patients With Haemophilia B

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Ended earlyNCT04394286
What this trial is testing

SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

Who this might be right for
Hemophilia B
Baxalta now part of Shire 2
Not applicableEnded earlyNCT00062231
What this trial is testing

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more
European Organisation for Research and Treatment of Cancer - EORTC 351
Not applicableStudy completedNCT00244114
What this trial is testing

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Not applicableStudy completedNCT07116993
What this trial is testing

Effects of Ultrasound and Infrared on Joint Pain and Movement in Hemophilia A Patients.

Who this might be right for
Hemophilia A
Danyal Ahmad 30
Not applicableActive Not RecruitingNCT04472169
What this trial is testing

UPLC-MS/MS Monitoring of Emicizumab Therapy

Who this might be right for
Hemophilia A
University Hospital, Lille 100
Not applicableStudy completedNCT02225483
What this trial is testing

Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function

Who this might be right for
Hemophilia A
CancerCare Manitoba 42
Testing effectiveness (Phase 2)Study completedNCT06144086
What this trial is testing

Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Who this might be right for
Liver Cirrhosis
Kiminori Kimura, MD 5
Not applicableLooking for participantsNCT02453542
What this trial is testing

Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors

Who this might be right for
Hemophilia
Karolinska Institutet 20
Not applicableStudy completedNCT06574984
What this trial is testing

Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 329
Large-scale testing (Phase 3)Study completedNCT01440946
What this trial is testing

Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 30
Large-scale testing (Phase 3)Study completedNCT03855280
What this trial is testing

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 21
Not applicableUnknownNCT05856903
What this trial is testing

Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer

Who this might be right for
Hemophilia A
University Hospital, Grenoble 15
Not applicableLooking for participantsNCT00001456
What this trial is testing

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome

Who this might be right for
Hermansky-Pudlak Syndrome (HPS)
National Human Genome Research Institute (NHGRI) 600
Not applicableStudy completedNCT02601170
What this trial is testing

Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy

Who this might be right for
HemophiliaHemophilic Arthropathy
Tri-Service General Hospital (TSGH) 22
Post-approval studies (Phase 4)Ended earlyNCT05856266
What this trial is testing

An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 10
Post-approval studies (Phase 4)Looking for participantsNCT07406139
What this trial is testing

PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A)

Who this might be right for
HemophiliaInhibitors
Institute of Hematology & Blood Diseases Hospital, China 30
Next Page